Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device.

about

Novel stroke risk reduction in atrial fibrillation: left atrial appendage occlusion with a focus on the Watchman closure device.

Item

http://www.wikidata.org/entity/Q39178470

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Novel stroke risk reduction in ...... n the Watchman closure device.

@en

Novel stroke risk reduction in ...... n the Watchman closure device.

@nl

type

Item

label

Novel stroke risk reduction in ...... n the Watchman closure device.

@en

Novel stroke risk reduction in ...... n the Watchman closure device.

@nl

prefLabel

Novel stroke risk reduction in ...... n the Watchman closure device.

@en

Novel stroke risk reduction in ...... n the Watchman closure device.

@nl

P1476

Novel stroke risk reduction in ...... n the Watchman closure device.

@en

P2093

Arash Alipour

http://www.w3.org/2001/XMLSchema#string

Benno J W M Rensing

http://www.w3.org/2001/XMLSchema#string

Jippe C Balt

http://www.w3.org/2001/XMLSchema#string

Lisette I S Wintgens

http://www.w3.org/2001/XMLSchema#string

Lucas V A Boersma

http://www.w3.org/2001/XMLSchema#string

Martin J Swaans

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: a systematic review and meta-analysis

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Dabigatran versus warfarin in patients with atrial fibrillation

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

Exclusion of the left atrial appendage with a novel device: early results of a multicenter trial.

P304

81-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/VHRM.S89213

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28293114

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

AVC

cerebrovascular disease

biomedical investigative technique

atrial fibrillation

P932

5345987

http://www.w3.org/2001/XMLSchema#string